CUSIP: 00211Y506
Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
2,614,171
-
Share change
-
-466,460
-
Total reported value
-
$6,185,189
-
Put/Call ratio
-
85%
-
Price per share
-
$2.36
-
Number of holders
-
21
-
Value change
-
-$935,435
-
Number of buys
-
10
-
Number of sells
-
9
Quarterly Holders Quick Answers
What is CUSIP 00211Y506?
CUSIP 00211Y506 identifies ABIO - ARCA BIOPHARMA INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2023
-
Previous quarter:
Q3 2022
Recent filing periods for CUSIP 00211Y506:
Institutional Holders of ARCA BIOPHARMA INC - COM (ABIO) as of Q4 2022
As of 31 Dec 2022,
ARCA BIOPHARMA INC - COM (ABIO) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,614,171 shares.
The largest 10 holders included
BML Capital Management, LLC, Newtyn Management, LLC, VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, Murchinson Ltd., BRIDGEWAY CAPITAL MANAGEMENT, LLC, DIMENSIONAL FUND ADVISORS LP, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
21
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.